8VC

Activity from announced rounds

Activity in this selectionMay 31, 2026 · May 1, 2026

8VC invests in and builds technology companies in life sciences, healthcare, manufacturing, enterprise software, logistics and defence.

Its Build programme creates companies when the team identifies an opportunity without an existing business to back. This adds a company-formation route to its conventional investment activity, relevant to entrepreneurs developing a technology platform from the outset.

The firm also runs engineering and Bio-IT fellowships connecting emerging technical talent with its companies. These programmes reflect its emphasis on recruiting builders for sectors where software, scientific expertise and physical operations intersect.

Sources
Rounds participated in
4
Confirmed lead rounds
—
4 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$1.3B
4 disclosed · full round size, not this investor’s share

By stage

Series A2
Growth1
Series B1

By primary sector

AI1
Biotech1
Fintech1
Hardware1

By country

United States3
United Kingdom1

Rounds

4 in this selection
Saris

Agentic workflow platform for banks and credit unions automating lending, compliance, and back-office operations

$28.8MSeries A
Role not disclosed
Cognition

Cognition develops Devin, an autonomous software-engineering system, and the Windsurf AI code editor.

$1BGrowth
Role not disclosed
Fractile

Builds custom inference chips designed to run frontier AI models faster by co-locating memory and compute

$220MSeries B
Role not disclosed
Latus Bio, Inc.

Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2

$97MSeries A
Role not disclosed